bluebird bio
BLUE
$0.90
Share price
-0.39%
Change (1 day)
-78.16%
Change (1 year)
bluebird bio (BLUE) - P/B ratio
P/B ratio as of May 2024 : 0.7824
According to bluebird bio
's latest financial reports the company has a price-to-book ratio of 0.7824.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
bluebird bio - P/B ratio (from 2013 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.20 | -59.1% |
| 2022-12-31 | 2.92 | 56.16% |
| 2021-12-31 | 1.87 | -11.71% |
| 2020-12-31 | 2.12 | -43.94% |
| 2019-12-31 | 3.78 | 31.26% |
| 2018-12-31 | 2.88 | -46.5% |
| 2017-12-31 | 5.38 | 103.37% |
| 2016-12-31 | 2.65 | -4.97% |
| 2015-12-31 | 2.79 | -53.86% |
| 2014-12-31 | 6.04 | 82.33% |
| 2013-12-31 | 3.31 | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | 1.50 | 91.99% | 🇫🇷 France |
 Merck MRK | 8.63 | 1,003.40% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | 1.31 | 67.03% | 🇺🇸 USA |
 GlycoMimetics
GLYC | 2.89 | 268.85% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 3.21 | 310.75% | 🇺🇸 USA |